J&J Exploring Putting Talc Liabilities Into Bankruptcy

Posted on Posted in Talcum Powder Cancer Link

July 18 (Reuters) – Johnson & Johnson (JNJ.N) is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection, according to seven people familiar with the matter. During settlement discussions, one of the healthcare conglomerate’s attorneys has told plaintiffs’ lawyers that J&J could pursue the […]

J&J Win In Asbestos-Talc Case Meets Skeptical Appeals Panel

Posted on Posted in Talcum Powder Cancer Link

By Hannah Albarazi A California appellate panel appeared skeptical Tuesday of Johnson & Johnson‘s summary judgment win in an asbestos-talc case, questioning the trial judge’s decision to preclude plaintiffs’ experts’ reliance on third-party testing finding asbestos in consumer talc and pressing J&J to explain its “magical” process for filtering out asbestos particles. All three judges on the […]

Miss. Supreme Court Affirms Order Rejecting J&J’s Challenges to AG’s Lawsuit Over Talcum Powder Labeling

Posted on Posted in Talcum Powder Cancer Link

JACKSON, Miss. –– Mississippi’s highest court will allow the state’s lawsuit against Johnson & Johnson for alleged mislabeling of talcum powder products to proceed, concluding that the underlying claims are neither preempted nor excluded under the Mississippi Consumer Protection Act. In the April 1 opinion, the Mississippi Supreme Court concluded that “the Food and Drug […]

Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

Posted on Posted in Uncategorized, Zyloprim and Allopurinol

By Deborah Levenson Be careful when prescribing allo¬purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels […]

Sanofi, GlaxoSmithKline Disclose DOJ Investigation Into Zantac After Recalls

Posted on Posted in Zantac

After global recalls of heartburn medicine Zantac and an FDA ban, the Department of Justice is investigating Sanofi and GlaxoSmithKline for possible violations of the False Claims Act. The drugmakers last year pulled their Zantac products over an impurity believed to cause cancer, and Sanofi said the probe is over disclosures relating to that impurity. GSK didn’t comment on the […]

FDA Uloric Warning Renews Concerns over Older Gout Drug Allopurinol

Posted on Posted in Zyloprim and Allopurinol

Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]

Johnson & Johnson’s $100 Million Baby Powder Lawsuit Settlement Is Overdue For Black & Hispanic Women

Posted on Posted in Talcum Powder Cancer Link

Forbes, Kori Hale Facing almost 20,000 lawsuits by women who blame  Johnson & Johnson’s talcum powder for causing cancer finally has a $100 million settlement from the manufacturer. The company agreed to settle 1,000 of these cases in bulk. Despite growing concerns of carcinogenic agents, the products giant continued to market and sell its baby […]